PRDS
Morgan Stanley’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-24,549
| Closed | -$44.4K | – | 7773 |
|
|
2023
Q2 | $44.4K | Sell |
24,549
-150,835
| -86% | -$273K | ﹤0.01% | 6257 |
|
|
2023
Q1 | $232K | Buy |
175,384
+155,272
| +772% | +$205K | ﹤0.01% | 5643 |
|
|
2022
Q4 | $34K | Sell |
20,112
-31,591
| -61% | -$53.4K | ﹤0.01% | 6455 |
|
|
2022
Q3 | $95K | Buy |
51,703
+7,576
| +17% | +$13.9K | ﹤0.01% | 6106 |
|
|
2022
Q2 | $135K | Buy |
44,127
+41,364
| +1,497% | +$127K | ﹤0.01% | 6111 |
|
|
2022
Q1 | $20K | Buy |
+2,763
| New | +$20K | ﹤0.01% | 7161 |
|
|
2021
Q4 | – | Sell |
-99
| Closed | -$1K | – | 8210 |
|
|
2021
Q3 | $1K | Buy |
+99
| New | +$1K | ﹤0.01% | 7847 |
|
|
2021
Q2 | – | Sell |
-119
| Closed | -$1K | – | 7840 |
|
|
2021
Q1 | $1K | Buy |
+119
| New | +$1K | ﹤0.01% | 7406 |
|